Fundraising FoxBiotech Startups
11,081 companies tagged Biotech, with their investors and founders.
NextEvo develops water-soluble CBD products using patented SmartSorb™ technology, validated through peer-reviewed clinical trials. The company applies pharmaceutical-grade science and standards to CBD formulations for consumer health markets.
0 investors
0 investors
0 investors
Nielsen BioSciences develops biopharmaceutical products that assess or treat immune responses, including skin test antigens for Valley Fever and candida infections, and investigational therapeutics for HPV-related lesions.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
NJ Bio, Inc. is a contract research and contract development and manufacturing organization (CRO/CDMO) providing integrated chemistry and biology services—including antibody-drug conjugates, bioconjugation, protein and antibody production, cell-based assays, nucleotide/oligonucleotide and mRNA synthesis, and bioanalytical work—to biotech and pharmaceutical companies. It is headquartered in Princeton, New Jersey, with additional chemistry facilities in Bristol, Pennsylvania and Mumbai, India.
0 investors
NK-One Therapeutics is a biotechnology company developing a first-in-class intrathecal molecular therapy (SP-SAP) that selectively disables NK-1 receptor pain-signaling neurons in the spine to treat refractory pain in end-stage cancer patients. The therapy is in a Phase 1 clinical trial and is also intended for veterinary use.
0 investors
NKore BioTherapeutics is a cellular-based biotherapeutics company developing an allogeneic immunotherapy platform based on a proprietary method of activating natural killer (NK) cells, called Supercharged NK (sNK) cells. Its lead therapy, NK101, targets solid and blood cancers in adult and pediatric patients, with human clinical trials planned in the United States beginning in 2027.
0 investors
Nobilis Therapeutics is a clinical-stage biotechnology company developing inhalation-based therapeutics that use controlled self-administration of inert gases to treat psychiatric and neurodegenerative diseases. It combines patent-pending gas mixtures with a proprietary inhalation device for standardized patient exposure and is advancing its technologies into human clinical trials.
0 investors
0 investors
0 investors
NOK Therapeutics is a biotech company developing autologous Natural Killer (NK) cell therapies for cancer treatment that avoid the need for lymphodepletion. The company is an early-stage oncology/immunotherapy business raising capital through a Regulation A+ pre-IPO offering.
0 investors
0 investors
0 investors
0 investors
Northwest Medical Isotopes (NWMI) is designing, licensing, and building a radioisotope production facility to process low-enriched uranium targets and produce fission-based Molybdenum-99 (Mo-99), the parent isotope for Tc-99m used in nuclear medicine imaging. It aims to supply a domestic and worldwide source of pharmaceutical-grade Mo-99 to radiopharmacies and medical imaging centers, with its production facility planned in Columbia, Missouri.
0 investors
0 investors
0 investors
Noumea Biosciences is a biotechnology company developing a therapeutic platform. It is based in Boston.
0 investors